gracecastuc-045_lung_which lung cancer patients should we be doing molecular marker testing for?
Published 11 years ago • 49 plays • Length 2:18Download video MP4
Download video MP3
Similar videos
-
0:50
dr. david spigel on "which molecular marker tests do you seek?"
-
1:45
gracecastuc-048_lung_what molecular markers do you prioritize for adv. nsclc, and who to test?
-
1:38
gracecastuc-049_lung_seek and use molecular marker information in patients with early stage nsclc?
-
16:39
gracecast-067_lung-cancer_expert round table - nsclc molecular markers case 3
-
20:06
gracecast-065_lung-cancer_expert round table - nsclc molecular markers
-
6:11
gracecastuc-012_lung_the more you seek, the more you find
-
5:11
gracecastuc-015_lung_what is the biology of a mixed response in lung cancer?
-
2:01
should we use dna or rna for ngs? - 2022 program: targeted therapies forum
-
17:28
gracecast-098_lung-cancer_mm in lc pt 3: who to test and what to test for -- panel discussion
-
2:11
gracecastuc-039_lung_how i use molecular marker information in earlier stage nsclc patients
-
1:45
gracecastuc-076_lung_utility of molecular marker results in adjuvant setting for early stage nsclc
-
1:35
gracecastuc 122 lung_dr. goldberg on which patients to seek molecular testing
-
1:59:57
grace - global resource for advancing cancer education live stream
-
21:33
optimal ngs platforms, how to interpret - grace targeted therapies in lung cancer patient forum 2021
-
5:09
gracecastuc-013_lung_what should we do for a "mixed response" to lung cancer treatment?
-
5:42
gracecastuc-006 - which patients with advanced lung cancer should potentially receive local therapy?
-
3:56
preferential timing for molecular testing in nsclc
-
0:13
the importance of biomarker testing- targeted therapies in lung cancer 2023- #shorts #youtubeshorts
-
10:10
gracecast-017_lung-cancer_never-smokers with lung cancer